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Copyright © 200? JCBN Summary D-psicose is one of the rare sugars present in small quantities in commercial
carbohydrates and agricultural products. In this study, we investigated the effects of D-psicose
on the activities of α-amylases and α-glucosidases  in vitro, and evaluated the effects of D-
psicose on the in vivo postprandial glycemic response using rats. In the in vitro study, D-psicose
potently inhibited the intestinal sucrase and maltase, however, slightly inhibited the intestinal
and salivary α-amylase activities. Male Wistar rats (6 months old) were administrated 2 g/kg
of sucrose, maltose or soluble starch together with 0.2 g/kg of D-psicose or D-fructose. The
D-psicose significantly inhibited the increment of plasma glucose concentration induced by
sucrose or maltose. The starch-induced glycemic response tended to be suppressed by D-
psicose, however the suppression was not significant. These results suggest that D-psicose
inhibits intestinal sucrase and maltase activities and suppresses the plasma glucose increase
the normally occurs after sucrose and maltose ingestion. Thus, D-psicose may be useful in
preventing postprandial hyperglycemia in diabetic patients when foods containing sucrose and
maltose are ingested.
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Introduction
D-psicose (D-ribo-2-hexulose), a C-3 epimer of D-fructose,
is a “rare sugar” present in small quantities in commercial
mixtures of D-glucose and D-fructose obtained from the
hydrolysis of sucrose or isomerization of D-glucose [1].
Because of the very small amounts of D-psicose in natural
products, few studies have examined D-psicose metabolism
in animals. Recently, we developed a new method for
producing  D-psicose enzymatically on a large scale [2],
making it possible to conduct such studies. We have since
demonstrated that D-psicose is a sweet carbohydrate that
provides no energy to growing rats [3–5] and that it causes
little toxic effect in rats [6–7]. Thus, D-psicose may be useful
as a sweetener for obese people seeking to lose weight.
On the other hand, it has been proven that strict glycemic
control is associated with a low incidence of microvascular
and macrovascular complications in diabetes [8], and a delay
or inhibition of carbohydrate digestion could be helpful for
avoiding postprandial hyperglycemia in diabetic patients
[9, 10]. Specific inhibitors of α-glucosidases have shown a
definite therapeutic value in suppressing the postprandial
glycemic increase by delaying carbohydrate digestion [9–11].
Acarbose [9–13] and L-arabinose [14–17] are known to be
competitive and uncompetitive inhibitors of the intestinal
α-glucosidases, ie, sucrase, and maltase. It has also been
shown that pancreatic amylase is inhibited by acarbose [13].
Although the majority of dietary carbohydrates are starch,
daily ingestion of sucrose is large in many advanced
countries, however, agents that inhibit neither starch nor
sucrose digestion have been used.
Previously, we reported that a diet containing 5% D-
psicose increased liver glycogen content in rats fed a high-fat
or a low-fat diet for 16 weeks [18]. We also observed that
D-psicose significantly suppressed the increment of plasmaEffects of D-psicose on Glycemic Response
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glucose concentration induced by oral carbohydrate (sucrose,
maltose or starch) tolerance tests [19]. In addition, we
demonstrated that plasma glucose and insulin concentrations
were lower in all days the rats were fed a D-psicose diet than
in the rats fed a sucrose diet for 8 weeks [20]. These findings
suggest that D-psicose may inhibit the activities of α-
amylase and α-glucosidase. However, inhibitory effects of
D-psicose on enzymes in the digestive tract were not
clarified. In this study, we investigated the effects of D-
psicose on the activities of α-amylases and α-glucosidases
in vitro, and evaluated the effects of D-psicose on the in vivo
postprandial glycemic response using rats.
Materials and Methods
All procedures involving animals were approved by the
Animal Care Committee of Kagawa University.
Inhibitory effect of D-psicose on activities of α-amylases and
α-glucosidases in vitro
D-Psicose and D-allose were donated from Rare Sugar
Research Center, Kagawa University. α-Amylases from
bacillus subtilis and aspergillus oryzae were purchased
from Wako Pure Chemical Industries (Osaka, Japan). Three
male Wistar rats (3-week-old) obtained from Japan SLC
(Shizuoka, Japan) were killed by decapitation. The small
intestines and pancreases of the rats were obtained
immediately after death, rinsed with ice-cold saline, and
stored at –40°C until use. All of the collected mucosa from
the three rats was homogenized together with a 5 mmol/l
EDTA-phosphate buffer (pH 7.0) and centrifuged at 4°C for
10 min at 15000 × g. The extract was used to assay of the
activities of α-amylase, sucrase, and maltase by methods of
Caspary and Graf [12] and Dahlqvist [21]. For the pancreatic
α-amylase assay, the tissues were homogenized together
with a 10 mmol/l phosphate buffer (pH 7.0), and the homo-
genate was used for amylase assay using the method of
Whelan [22]. The standard assay mixture contained a 40 μl
substrate solution (20 mg/ml soluble starch, sucrose, and
maltose, for assay of α-amylase, sucrase, and maltase,
respectively), and 80 μl of a test carbohydrate solution (final
concentration, 0.4–4.0 mg/ml D-fructose, D-psicose, and D-
allose). The reaction was initiated by the addition of 80 μl
of appropriate dilutions of dried enzyme powders (from
bacillus subtilis and aspergillus oryzae) or enzyme solutions
(from the small intestine and pancreas). The reaction mixture
was incubated for 60 min at 37°C, and then the glucose
concentration of the mixture was determined by the kits
(Glucose CII-Test, Wako Pure Chemical Industries). The
relative enzyme activities were calculated from glucose
release. Relative rates were shown as 100% without inhibitors.
Effect of D-psicose on plasma glucose concentrations after
carbohydrate loading in rats
To evaluate the potency of D-psicose in vivo, the effects of
D-psicose on plasma glucose concentrations after glucose,
sucrose, maltose, and soluble starch loading, were examined.
One hundred forty-four male Wistar rats (6 months old)
were purchased from Japan SLC (Shizuoka, Japan) and
acclimatized for a week under standard laboratory condi-
tions (22 ± 2°C, 60% humidity). The light/dark cycle was
12 h with lights on from 8:00 h to 20:00 h. Rats were
Table 1. Inhibitory effect of rare sugars on glucose release by α-amylase and α-glucosidase
Values are the means ± SD of four experiments. Relative rates are shown as 100% without inhibitor. Means with different superscripts
within a column are significantly different (p<0.05, one-way ANOVA and Fisher’s PLSD tests).
Enzymes
Substrate/
inhibitor
D-Fructose D-Psicose D-Allose
Relative rate (%)
α-Amylase (rat small intestine) 1 100.8 ± 1.0a 83.0 ± 1.9c 89.5 ± 1.9b
10 101.2 ± 2.0 100.2 ± 1.4 100.4 ± 0.6
α-Amylase (rat pancrease) 1 100.7 ± 0.4 100.4 ± 1.1 101.6 ± 1.1
10 98.5 ± 1.7 98.0 ± 1.2 101.3 ± 2.9
α-Amylase (human saliva) 1 101.3 ± 1.5 96.2 ± 3.3 103.7 ± 3.3
10 101.5 ± 0.9 99.9 ± 2.3 99.3 ± 2.3
α-Amylase (bacillus subtilis) 1 102.4 ± 3.1 102.3 ± 5.3 101.7 ± 2.9
10 99.1 ± 0.2 99.1 ± 0.2 98.3 ± 0.8
α-Amylase (aspergillus oryzae) 1 95.0 ± 1.7a 89.3 ± 0.6b 95.3 ± 1.1a
10 98.8 ± 0.5 97.5 ± 0.3 98.0 ± 1.0
Sucrase (rat small intestine) 1 99.6 ± 2.6a 74.5 ± 3.9b 77.9 ± 1.3b
10 98.1 ± 1.5a 92.2 ± 2.3b 96.4 ± 1.3ab
Maltase (rat small intestine) 1 99.5 ± 3.4a 85.4 ± 2.6b 90.2 ± 5.6ab
10 100.9 ± 0.5 101.0 ± 0.3 99.7 ± 0.2T. Matsuo and K. Izumori
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randomly divided into the 12 groups shown in Table 1.
Twelve rats were fasted overnight for 12 h before the experi-
ments. D-Psicose, or D-fructose (0.2 g/kg) was orally admin-
istered via gavage with 2 g/kg glucose, sucrose, maltose, or
soluble starch. At 0, 30, 60, 90, and 120 min after loading,
blood was collected from the tail vein to obtain the plasma.
The plasma glucose concentration was determined by the
kits (Glucose CII-Test, Wako Pure Chemical Industries).
Statistical analysis
All values are expressed as the mean ± SD. The data was
assessed by one-way ANOVA and Fisher’s PLSD tests. All
analyses were performed with a commercially available
statistical package (StatView J-5.0, SAS Institute Inc., Cary,
NC).
Results
Inhibitory effect of D-psicose on activities of α-amylases and
α-glucosidases in vitro
Relative enzyme activities shown in Table 1 are 100%
without inhibitors (D-fructose,  D-psicose, or D-allose).  D-
Fructose (0.4–4.0 mg/ml) showed no inhibition of each
enzyme activity (Table 1).  D-Psicose and D-allose (4.0 mg/
ml)  significantly inhibited intestinal α-amylase, sucrase,
maltase, and α-amylase from aspergillus oryzae (Table 1)
except for in the maltase inhibition induced by D-allose.
The inhibitory effect of D-psicose was greater than that of
D-allose (Table 1). Neither D-psicose nor D-allose inhibited
the pancreatic α-amylase, and α-amylase from bacillus
subtilis activities (Table 1). D-Psicose (4.0 mg/ml) slightly
inhibited the salivary α-amylase activity, but D-allose did
not suppress this enzyme (Table 1).
Effect of D-psicose on plasma glucose concentrations after
carbohydrate loading in rats
D-Psicose significantly suppressed the increase of plasma
glucose levels after sucrose and maltose loading in fasted
rats, however, no suppression was found after glucose
loading (Table 2). After 60 min after ingestion, the plasma
glucose concentration was significantly lower in the
Sucrose + Psicose group than in the Sucrose group, the
suppression lasted from 30 to 90 min in the Sucrose +
Psicose group (Table 2). At 30, 90 and 120 min after inges-
tion, the plasma glucose concentration was significantly
lower in the Maltose + Psicose group than in the Maltose
group, and the suppression lasted from 30 to 120 min in
the Maltose + Psicose group (Table 2). The plasma glucose
level was also suppressed by D-psicose after starch loading
in fasted rats, however, the suppression was not significant.
D-Fructose did not suppress the increase of plasma glucose
levels after either carbohydrate loading (Table 2).
Discussion
We demonstrated in this study that D-psicose selectively
inhibited the intestinal α-amylase, sucrase, and maltase
activities. We also showed that D-psicose suppressed the
increase of plasma glucose after ingestion of sucrose,
maltose, and starch in rats, but the plasma glucose suppres-
sion was not significant after starch ingestion. Semenza and
Balthazar [23] and Seri et al. [14] reported a similar inhibi-
Table 2. Effects of D-psicose on plasma glucose concentrations (mg/dL) after oral carbohydrate loading in rats
Values are the means ± SD for 12 rats. Fructose and psicose (0.2 g/kg body weight) were administered with glucose, sucrose, maltose or
starch (2 g/kg body weight). Means with different superscripts within a column are significantly different (p<0.05, one-way ANOVA and
Fisher’s PLSD tests).
Test carbohydrates
Time after administration (min) ΔAUC 
(h·mg/dL) 0 3 06 09 0 1 2 0
Glucose 99 ± 7 148 ± 14 157 ± 15 159 ± 71 6 8 ± 18 6087 ± 1160
Glucose+Fructose 92 ± 8 139 ± 12 154 ± 17 156 ± 18 159 ± 18 6530 ± 1194
Glucose+Psicose 92 ± 10 140 ± 14 154 ± 10 154 ± 16 155 ± 13 5866 ± 1434
Sucrose 102 ± 8 135 ± 13 151 ± 27a 148 ± 14 146 ± 17 5235 ± 1692
Sucrose + Fructose 102 ± 12 134 ± 13 142 ± 11ab 146 ± 10 144 ± 9 4109 ± 1106
Sucrose + Psicose 95 ± 9 129 ± 11 138 ± 12b 146 ± 16 142 ± 17 4433 ± 1654
Maltose 94 ± 9 146 ± 12a 157 ± 19 163 ± 17a 159 ± 12a 6855 ± 1383
Maltose + Fructose 88 ± 12 140 ± 12ab 155 ± 15 152 ± 9ab 147 ± 12ab 6386 ± 1430
Maltose + Psicose 87 ± 9 133 ± 18b 149 ± 13 147 ± 12b 141 ± 16b 5895 ± 1061
Starch 98 ± 10 131 ± 10 133 ± 18 130 ± 17 125 ± 19 4035 ± 1233
Starch + Fructose 93 ± 4 128 ± 14 134 ± 16 127 ± 12 126 ± 11 3836 ± 1330
Starch + Psicose 92 ± 9 124 ± 11 125 ± 15 121 ± 12 120 ± 12 3098 ± 1138Effects of D-psicose on Glycemic Response
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tion of sucrase activity by L-arabinose in rabbits [23] and
rats [14], however, they did not examine the intestinal α-
amylase activity. We also showed that D-allose selectively
inhibited the activities of intestinal enzymes in vitro, but no
in vivo examination was performed in this experiment. In
our previous study, we demonstrated that a diet containing
5%  D-psicose increased liver glycogen content in rats fed
a  high-fat or a low-fat diet for 16 weeks [18]. We also
observed that D-psicose significantly suppressed the incre-
ment of plasma glucose concentration induced by oral
carbohydrate (sucrose, maltose or starch) tolerance tests
[19]. The present study supports our previous findings.
Other α-glucosidase inhibitors [9–13, 24] such as acarbose
are recognized as potent inhibitors of the activities of
intestinal glucoamylase, maltase, and sucrase, and it has
also been shown that acarbose has an inhibitory effect on
pancreatic amylase activity [13]. In many advanced countries,
starch accounts for approximately 60% of ingested carbo-
hydrates, with sucrose accounting for 30%, and lactose
accounting for 10% [12]. Since the digestion of both starch
and sucrose are delayed by acarbose and D-psicose, these
α-glucosidase inhibitors have valuable therapeutic effect in
reducing postprandial hyperglycemia in diabetic patients.
The majority of dietary carbohydrates are from starch, but
sucrose is used in many foods as a sweetener or as another
ingredient, and its daily intake in many advanced countries
is large. It has been shown that Tris competitively inhibits
intestinal sucrose ingestion in rats and human subjects [25],
however, Tris is of no practical use, because of its unpleasant
taste and the necessity of large doses. Thus, there are few
known inhibitors of practical use such as L-arabinose that
selectively inhibit intestinal sucrase and delay the ingestion
of sucrose.
D-Psicose is a rare natural sugar with a sweet taste. In this
study, it suppressed the increase in plasma glucose after
sucrose (−15%, calculated by area under the curve, Table 2),
maltose (−14%), and starch (−23%) but showed no suppres-
sion of the increase in plasma glucose after oral glucose
loading in rats. These results suggest that D-psicose does
not affect glucose absorption or gastric emptying. Among
hexose structurally related to D-psicose,  D-allose was
equally potent in its inhibitory effect on the sucrose and mal-
tose activities of intestinal mucosa in this study. Neither D-
psicose nor D-allose inhibited amylases from rat pancreas,
bacillus subtilis, or aspergillus oryzae. These results suggest
that some specific interaction may exist among the enzymes,
inhibitors, and the substrate to elicit the inhibitory action of
D-psicose or D-allose.
D-Psicose is prevalent in nature as a component of some
plants and agricultural products [26–30]. It has a potent,
sweet taste and low toxicity; the LD50 value was 16g/kg
orally in rats in our previous tests [6]. D-Psicose caused no
diarrhea at a dose of 10% of the dietary intake in the rat
study [6]. Although a definite therapeutic value of other
known  α-glucosidase inhibitors in diabetic patients has
been demonstrated, unpleasant side effects associated with
incomplete absorption of dietary carbohydrates, ie, flatulence,
abdominal discomfort, diarrhea [9,  10], and ileus-like
symptoms [31], have been reported. These side effects may
be due to the potent inhibition of pancreatic amylases and
many intestinal enzymes, which in turn strongly inhibits the
digestion of both sucrose and starch. As shown in this study,
D-psicose only inhibited intestinal enzymes and the suppres-
sion of amylase was weak, resulting in little adverse effect
on the gastrointestinal tract.
Recently, there have been skeptical studies concerning the
long-term effects of α-glucosidase inhibitors, e.g. acarbose,
in type 2 diabetes patients. Kaiser et al. [32] and Van De
Laar et al. [33] reported that the long-term trials and meta-
analysis studies have been criticized for the effects of α-
glucosidase inhibitors. Furthermore, a recent systematic
review of α-glucosidase inhibitors in patients with type 2
diabetes concluded that there was no evidence of any effect
on morbidity or mortality [34]. It is not clear the hypo-
glycemic effects and side effects of D-psicose in diabetic
patients for long-term. However, these effects were clarified
in our previous animal studies [6, 20, 35]. Therefore, we will
examine the long-term effects of D-psicose in clinical studies
in future.
In conclusion, the present study demonstrated that D-
psicose inhibits intestinal sucrase and maltase activities
and suppresses the plasma glucose increase after sucrose and
maltose ingestion. Thus, D-psicose may be useful in pre-
venting postprandial hyperglycemia in diabetic patients
when foods containing sucrose and maltose are ingested.
This is the first report indicating inhibition of sucrase and
maltase activities by D-psicose both in vitro and in vivo.
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